Device Trial Radar · NCT06987474
Capella Scientia Development Study
Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
400
Planned (sponsor's estimate)
Start
Jul 30, 2025
Primary completion
May 2027
Study completion May 2027
Sponsor
- Lead sponsor
- Alcon ResearchNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 23, 2025
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
This study involves collecting biometry and aberration data using the next generation biometer, Unity DX.
Conditions
- Cataract
Interventions
Unity DX and SMARTCataract DX (SCDX) BiometerDevice
Unity DX is a CE-marked, noninvasive, noncontact instrument that generates a 3D model of the eye using hyper parallel optical coherence tomography (HP OCT), aberrometry, and topography. The current version of SCDX software will be used in this study.
IOLMaster 700 BiometerDevice
The IOLMaster 700 Biometer is a CE-marked, noninvasive, noncontact instrument that captures optical biometry. Data will be collected using standard clinical assessments.
Argos with Alcon Image Guidance BiometerDevice
The Argos with Alcon Image Guidance biometer is a CE-marked, noninvasive, noncontact instrument that will capture optical biometry. Data will be collected using standard clinical assessments.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Manifest Refraction Spherical Equivalent (MRSE)Time frame: Group 1 and Group 4: Day 0; Group 2 and Group 3: Screening (Day -30 to Day -1), Day 30 to 60 postoperative, Day 70 to 100 postoperative
Locations
5 sites in 4 countries. Site status is shown where the registry gives one.
The Eye Institute of Utah
Salt Lake City, Utah · Recruiting
Narayana Nethralaya
Bangalore, India · Not yet recruiting
Asian Eye Institute
Makati City, Philippines · Recruiting
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.